Company profile: Imricor
1.1 - Company Overview
Company description
- Provider of MRI-compatible electrophysiology tools for treating cardiac arrhythmias, including the Vision-MR Ablation Catheter for active MRI scanning with real-time visualization and individualized treatment without radiation exposure; the Advantage-MR EP Recorder/Stimulator for displaying and recording intracardiac electrograms, pacing, and tip temperature monitoring during iCMR procedures; and the Vision-MR Dispersive Electrode to minimize eddy currents during MR scanning.
Products and services
- Advantage-MR EP Recorder / Stimulator: An MRI-compatible electrophysiology amplifier and recording system with integrated cardiac stimulator enabling intracardiac electrogram display/recording, pacing, and tip temperature monitoring during iCMR procedures
- Vision-MR Ablation Catheter: A patented ablation catheter engineered for active MRI scanning, enabling real-time visualization and individualized cardiac arrhythmia treatment without radiation exposure
- Vision-MR Dispersive Electrode: An MRI-compatible dispersive electrode constructed to minimize eddy currents induced on the device’s conductive pads during MR scanning
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Imricor
Bivacor
HQ: United States
Website
- Description: Provider of centrifugal heart pumps, including the BiVACOR Total Artificial Heart, a long-term rotary blood pump device with magnetic levitation for patients with severe heart failure. Offers magnetic levitation to reduce mechanical wear, smart controllers that adapt pump operation to patient activity, and a portable external controller and batteries to enable mobility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bivacor company profile →
Orchestra BioMed
HQ: United States
Website
- Description: Provider of biomedical solutions for procedure-based medicine: BackBeat CNT (investigational bioelectronic treatment for hypertension to reduce blood pressure and modulate autonomic nervous system responses); Virtue SAB (investigational drug/device delivering sirolimus during angioplasty without coating or permanent implants); and FreeHold Retractors for hands-free surgical retraction to improve visualization and procedural efficiency.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Orchestra BioMed company profile →
Boston Heart Diagnostics
HQ: United States
Website
- Description: Provider of cardiovascular disease management solutions, combining proprietary lipid testing, advanced diagnostics, therapy guidelines, and patient support. Offerings include CVMap, Polygenic Risk Map, LipoMap NMR lipid panel, dried blood spot testing with 40+ assays, advanced lipid tests for risk stratification and chronic care, and a tailored lifestyle program for long-term health.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Boston Heart Diagnostics company profile →
Affera
HQ: United States
Website
- Description: Provider of an integrated platform for cardiac arrhythmia treatment delivering durable therapy for a wide range of patients, and pulsed field ablation for atrial fibrillation using a lattice-tip focal catheter.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Affera company profile →
Percutaneous Valve Technologies
HQ: United States
Website
- Description: Provider of medical devices for delivering heart valves to treat late-stage aortic stenosis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Percutaneous Valve Technologies company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Imricor
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Imricor
2.2 - Growth funds investing in similar companies to Imricor
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Imricor
4.2 - Public trading comparable groups for Imricor
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →